220 related articles for article (PubMed ID: 28858854)
1. Photon iso-effective dose for cancer treatment with mixed field radiation based on dose-response assessment from human and an animal model: clinical application to boron neutron capture therapy for head and neck cancer.
González SJ; Pozzi ECC; Monti Hughes A; Provenzano L; Koivunoro H; Carando DG; Thorp SI; Casal MR; Bortolussi S; Trivillin VA; Garabalino MA; Curotto P; Heber EM; Santa Cruz GA; Kankaanranta L; Joensuu H; Schwint AE
Phys Med Biol; 2017 Oct; 62(20):7938-7958. PubMed ID: 28858854
[TBL] [Abstract][Full Text] [Related]
2. Histamine reduces boron neutron capture therapy-induced mucositis in an oral precancer model.
Monti Hughes A; Pozzi E; Thorp SI; Curotto P; Medina VA; Martinel Lamas DJ; Rivera ES; Garabalino MA; Farías RO; Gonzalez SJ; Heber EM; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
Oral Dis; 2015 Sep; 21(6):770-7. PubMed ID: 25926141
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Photon Isoeffective Dose Models Based on In Vitro and In Vivo Radiobiological Experiments for Head and Neck Cancer Treated with BNCT.
Perotti Bernardini GF; Bortolussi S; Koivunoro H; Provenzano L; Ferrari C; Cansolino L; Postuma I; Carando DG; Kankaanranta L; Joensuu H; González SJ
Radiat Res; 2022 Aug; 198(2):134-144. PubMed ID: 35504003
[TBL] [Abstract][Full Text] [Related]
4. Boron Neutron Capture Therapy (BNCT) in an oral precancer model: therapeutic benefits and potential toxicity of a double application of BNCT with a six-week interval.
Monti Hughes A; Pozzi EC; Heber EM; Thorp S; Miller M; Itoiz ME; Aromando RF; Molinari AJ; Garabalino MA; Nigg DW; Trivillin VA; Schwint AE
Oral Oncol; 2011 Nov; 47(11):1017-22. PubMed ID: 21840244
[TBL] [Abstract][Full Text] [Related]
5. Boron neutron capture therapy for oral precancer: proof of principle in an experimental animal model.
Monti Hughes AM; Pozzi EC; Thorp S; Garabalino MA; Farías RO; González SJ; Heber EM; Itoiz ME; Aromando RF; Molinari AJ; Miller M; Nigg DW; Curotto P; Trivillin VA; Schwint AE
Oral Dis; 2013 Nov; 19(8):789-95. PubMed ID: 23410091
[TBL] [Abstract][Full Text] [Related]
6. Tumor blood vessel "normalization" improves the therapeutic efficacy of boron neutron capture therapy (BNCT) in experimental oral cancer.
Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
Radiat Res; 2012 Jan; 177(1):59-68. PubMed ID: 21980958
[TBL] [Abstract][Full Text] [Related]
7. The photon-isoeffective dose in boron neutron capture therapy.
González SJ; Santa Cruz GA
Radiat Res; 2012 Dec; 178(6):609-21. PubMed ID: 23148506
[TBL] [Abstract][Full Text] [Related]
8. Using the photon isoeffective dose formalism to compare and combine BNCT and CIRT in a head and neck tumour.
Postuma I; Magni C; Marcaccio B; Fatemi S; Vercesi V; Ciocca M; Magro G; Orlandi E; Vischioni B; Ronchi S; Liu YH; Han Y; Geng C; González SJ; Bortolussi S
Sci Rep; 2024 Jan; 14(1):418. PubMed ID: 38172585
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy (BNCT) translational studies in the hamster cheek pouch model of oral cancer at the new "B2" configuration of the RA-6 nuclear reactor.
Monti Hughes A; Longhino J; Boggio E; Medina VA; Martinel Lamas DJ; Garabalino MA; Heber EM; Pozzi ECC; Itoiz ME; Aromando RF; Nigg DW; Trivillin VA; Schwint AE
Radiat Environ Biophys; 2017 Nov; 56(4):377-387. PubMed ID: 28871389
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution of GB-10 (Na(2)(10)B10H10 compound for boron neutron capture therapy (BNCT) in an experimental model of oral cancer in the hamster cheek pouch.
Heber E; Trivillin VA; Nigg D; Kreimann EL; Itoiz ME; Rebagliati RJ; Batistoni D; Schwint AE
Arch Oral Biol; 2004 Apr; 49(4):313-24. PubMed ID: 15003550
[TBL] [Abstract][Full Text] [Related]
11. Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch.
Kreimann EL; Miura M; Itoiz ME; Heber E; Garavaglia RN; Batistoni D; Rebagliati RJ; Roberti MJ; Micca PL; Coderre JA; Schwint AE
Arch Oral Biol; 2003 Mar; 48(3):223-32. PubMed ID: 12648560
[TBL] [Abstract][Full Text] [Related]
12. "Sequential" boron neutron capture therapy (BNCT): a novel approach to BNCT for the treatment of oral cancer in the hamster cheek pouch model.
Molinari AJ; Pozzi EC; Monti Hughes A; Heber EM; Garabalino MA; Thorp SI; Miller M; Itoiz ME; Aromando RF; Nigg DW; Quintana J; Santa Cruz GA; Trivillin VA; Schwint AE
Radiat Res; 2011 Apr; 175(4):463-72. PubMed ID: 21294607
[TBL] [Abstract][Full Text] [Related]
13. Homogeneous boron targeting of heterogeneous tumors for boron neutron capture therapy (BNCT): chemical analyses in the hamster cheek pouch oral cancer model.
Heber EM; Trivillin VA; Nigg DW; Itoiz ME; Gonzalez BN; Rebagliati RJ; Batistoni D; Kreimann EL; Schwint AE
Arch Oral Biol; 2006 Oct; 51(10):922-9. PubMed ID: 16696934
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic effect of boron neutron capture therapy (BNCT) on field cancerized tissue: inhibition of DNA synthesis and lag in the development of second primary tumors in precancerous tissue around treated tumors in DMBA-induced carcinogenesis in the hamster cheek pouch oral cancer model.
Heber EM; Aromando RF; Trivillin VA; Itoiz ME; Nigg DW; Kreimann EL; Schwint AE
Arch Oral Biol; 2007 Mar; 52(3):273-9. PubMed ID: 17137553
[TBL] [Abstract][Full Text] [Related]
15. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME
Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008
[TBL] [Abstract][Full Text] [Related]
16. Detailed dosimetry calculation for in-vitro experiments and its impact on clinical BNCT.
Viegas AMD; Postuma I; Bortolussi S; Guidi C; Riback JS; Provenzano L; Marcaccio B; Rossini AE; Ferrari C; Cansolino L; Ferrari M; Portu AM; González SJ
Phys Med; 2021 Sep; 89():282-292. PubMed ID: 34474326
[TBL] [Abstract][Full Text] [Related]
17. Boron neutron capture therapy for the treatment of oral cancer in the hamster cheek pouch model.
Kreimann EL; Itoiz ME; Longhino J; Blaumann H; Calzetta O; Schwint AE
Cancer Res; 2001 Dec; 61(24):8638-42. PubMed ID: 11751376
[TBL] [Abstract][Full Text] [Related]
18. Dosimetry and radiobiology at the new RA-3 reactor boron neutron capture therapy (BNCT) facility: application to the treatment of experimental oral cancer.
Pozzi E; Nigg DW; Miller M; Thorp SI; Heber EM; Zarza L; Estryk G; Monti Hughes A; Molinari AJ; Garabalino M; Itoiz ME; Aromando RF; Quintana J; Trivillin VA; Schwint AE
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S309-12. PubMed ID: 19380233
[TBL] [Abstract][Full Text] [Related]
19. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
[TBL] [Abstract][Full Text] [Related]
20. Understanding the potentiality of accelerator based-boron neutron capture therapy for osteosarcoma: dosimetry assessment based on the reported clinical experience.
Bortolussi S; Postuma I; Protti N; Provenzano L; Ferrari C; Cansolino L; Dionigi P; Galasso O; Gasparini G; Altieri S; Miyatake SI; González SJ
Radiat Oncol; 2017 Aug; 12(1):130. PubMed ID: 28806981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
